Intelligent Cavitation-Enhanced Drug Treatment Planning System

Publication ID: 24-11857807_0003_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Intelligent Cavitation-Enhanced Drug Treatment Planning System,” Published Technical Disclosure No. 24-11857807_0003_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857807_0003_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,807.

Summary of the Inventive Concept

A novel system integrating AI, IoT, blockchain, and simulation-based technology to optimize cavitation-enhanced drug treatment planning, ensuring personalized, secure, and efficient treatment outcomes.

Background and Problem Solved

The original patent disclosed a system for simulating and adjusting cavitation-enhanced drug-treatment procedures prior to execution. However, it lacked the integration of advanced technologies to enhance its capabilities. The new inventive concept addresses this limitation by combining AI, IoT, blockchain, and simulation-based technology to provide a more comprehensive and effective drug treatment planning system.

Detailed Description of the Inventive Concept

The Intelligent Cavitation-Enhanced Drug Treatment Planning System consists of a neural network-based simulation module, a database storing historical treatment data and outcomes, and a recommendation engine for suggesting optimized treatment protocols. The system utilizes AI-driven ultrasound image analysis, IoT-enabled ultrasound devices for real-time monitoring and adjustment, and a blockchain-based decentralized data management system for secure and transparent data storage and access. The system predicts treatment outcomes, provides personalized treatment planning, and enables real-time monitoring and adjustment of cavitation-enhanced drug-treatment procedures.

Novelty and Inventive Step

The new claims introduce the integration of AI, IoT, and blockchain technologies with simulation-based drug treatment planning, providing a novel and non-obvious solution that enhances the capabilities of the original patent. The inventive step lies in the synergistic combination of these technologies to create a more powerful and effective drug treatment planning system.

Alternative Embodiments and Variations

Alternative embodiments may include the use of different AI algorithms, varying IoT device configurations, or alternative blockchain architectures. Additionally, the system could be adapted for use in other medical applications, such as gene therapy or cancer treatment.

Potential Commercial Applications and Market

The Intelligent Cavitation-Enhanced Drug Treatment Planning System has significant commercial potential in the healthcare industry, particularly in the fields of neurology, oncology, and gene therapy. The system's ability to provide personalized, secure, and efficient treatment outcomes makes it an attractive solution for pharmaceutical companies, hospitals, and research institutions.

Original Patent Information

Patent NumberUS 11,857,807
TitleSimulation-based drug treatment planning
Assignee(s)INSIGHTEC, LTD.